Bank Of America Corp Vanda Pharmaceuticals Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 77,418 shares of VNDA stock, worth $382,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,418

Previous 1,208,261 93.59%

Holding current value

$382,444

Previous $4.97 Million 91.2%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $4.42 Million - $7.35 Million	-1,130,843 Reduced 93.59%	77,418 $437,000
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $4.1 Million - $5.44 Million	1,181,116 Added 4351.14%	1,208,261 $4.97 Million
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $1.05 Million - $1.43 Million	-311,780 Reduced 91.99%	27,145 $114,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $7.62 Million - $8.98 Million	-1,292,215 Reduced 79.22%	338,925 $2.23 Million
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $8.32 Million - $10.8 Million	1,345,529 Added 471.11%	1,631,140 $11.1 Million
Q4 2022 Feb 10, 2023	SELL	$6.87 - $10.96 $428,097 - $682,961	-62,314 Reduced 17.91%	285,611 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $1.23 Million - $1.54 Million	-130,784 Reduced 27.32%	347,925 $3.44 Million
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $1.56 Million - $1.99 Million	167,879 Added 54.01%	478,709 $5.22 Million
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $837,064 - $1.28 Million	-77,220 Reduced 19.9%	310,830 $3.52 Million
Q4 2021 Feb 08, 2022	BUY	$15.69 - $21.14 $1.26 Million - $1.7 Million	80,274 Added 26.08%	388,050 $6.09 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $456,094 - $631,995	29,713 Added 10.69%	307,776 $5.28 Million
Q2 2021 Sep 13, 2021	BUY	$15.71 - $21.51 $4.37 Million - $5.98 Million	278,063 New	278,063 $5.98 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

45.1M

Call Options Held

136K

Put Options Held

220K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $279M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Vanda Pharmaceuticals Inc. Transaction History